Five things for pharma marketers to know: Wednesday, January 18, 2017

Rep. Price to answer questions at confirmation hearing; 22 drugmakers invest in fighting disease in poor countries; FDA approves generic of Jazz's Xyrem

If CSL Limited CEO Paul Perreault sneezes, Australia gets a cold

"In Australia, we are the healthcare industry," he says.

The FDA targeted DTC, video, unapproved drug promotion in 2016

The FDA targeted DTC, video, unapproved drug promotion in 2016

The agency issued 11 enforcement letters last year.

Trump administration raises questions for rare-disease drugmakers

Trump administration raises questions for rare-disease drugmakers

Nobody knows what the future holds for the Affordable Care Act under the Trump administration and an emboldened Republican Congress.

Klick Health's Elliot Langerman on the Power of Persuasion

Klick Health's Elliot Langerman on the Power of Persuasion

Here are six global campaigns that make the case for persuasion.

Industry hires and promotions: January 2017

Industry hires and promotions: January 2017

Endo hires new head of U.S. branded pharma, and three other people moves for you to know about.

Five things for pharma marketers to know: Tuesday, January 17, 2017

Five things for pharma marketers to know: Tuesday, January 17, 2017

Biogen to pay $1.25 billion for patents to MS drugs; Supreme Court to hear Novartis case over Zarxio delay; Merck KGaA inks big-data deal

Five things for pharma marketers to know: Friday, January 13, 2017

Five things for pharma marketers to know: Friday, January 13, 2017

CVS to sell generic EpiPen; FDA finalizes biosimilar naming rules; Pfizer wants to make a deal

GCI Health plants its flag in Philadelphia

GCI Health plants its flag in Philadelphia

The firm is sharing space in the City of Brotherly Love with healthcare media shop CMI.

Day 3 at JP Morgan: The move toward big data requires drugmakers to ask questions

Day 3 at JP Morgan: The move toward big data requires drugmakers to ask questions

There are dozens of players, including leaders like IBM Watson Health and Verily as well as smaller concerns, lining up to sell pharma access to some sort of data solution.

Five things for pharma marketers to know: Thursday, January 12, 2017

Five things for pharma marketers to know: Thursday, January 12, 2017

Trump says pharma is "getting away with murder"; Senate majority votes to repeal ACA; IBM Watson Health and FDA to study blockchain technology

Merck's Keytruda combo could edge out the competition

Merck's Keytruda combo could edge out the competition

Merck said the FDA accepted its submission of a Keytruda/chemotherapy combo drug and granted it Priority Review.

Day 2 at JP Morgan: Change is coming, but which drugmakers will stay on top?

Day 2 at JP Morgan: Change is coming, but which drugmakers will stay on top?

J&J's CEO may be right. Customers of all kinds are demanding change.

Five things for pharma marketers to know: Wednesday, January 11, 2017

Five things for pharma marketers to know: Wednesday, January 11, 2017

The FDA accepts Keytruda combo for review; Valeant offloads Dendreon and skincare brands; pharmacies feeling the squeeze from Express Scripts

Tonic Life promotes Stephanie DeViteri to MD

Tonic Life promotes Stephanie DeViteri to MD

DeViteri started in the newly created role this month.

Physicians group urges metformin rather than new drugs

Physicians group urges metformin rather than new drugs

The American College of Physicians said the costs of some new diabetes drugs do not always mean added benefits for patients.

Infographic: Can pharma give doctors what they want?

Infographic: Can pharma give doctors what they want?

Physicians do not like EHRs. That much is clear. But the vast majority have to use electronic record systems on a daily basis. What can pharma do to better give doctors what they want?

Day 1 at JP Morgan: Pricing is top of mind for pharma CEOs

Day 1 at JP Morgan: Pricing is top of mind for pharma CEOs

The questions being asked about how drugs are priced are weighing heavily on pharma leaders, and they know the issue is not going away.

Five things for pharma marketers to know: Tuesday, January 10, 2017

Five things for pharma marketers to know: Tuesday, January 10, 2017

Illumina and IBM enter DNA sequencing partnership; J&J to outline price increases in new report; Egalet's opioid Arymo ER gets FDA approval

Top 25 cardiovascular brands, 2015-2016

Top 25 cardiovascular brands, 2015-2016

The top-selling heart drug is Merck's Zetia, which is expected to bring in about $1.68 billion in sales in 2016.

Agency Spotlight

Featured Listings

LevLane

LevLane

Featured Work: Kennedy Health brings sophisticated healthcare to South Jersey, and we wanted this ...

OPINION

Healthcare Marketers: The Future is Personal

Email Newsletters